AMENDMENT NO. 2 TO FIFTH AMENDED AND RESTATED CREDIT AGREEMENTCredit Agreement • April 18th, 2023 • Iqvia Holdings Inc. • Services-commercial physical & biological research • New York
AMENDMENT NO. 2, dated as of April 17, 2023 (this “Amendment”), among IQVIA Inc., a Delaware corporation (the “Parent Borrower”), IQVIA RDS Inc. a North Carolina corporation and a subsidiary of the Parent Borrower (the “U.S. Borrower”), IQVIA AG, a Swiss corporation and a subsidiary of the Parent Borrower (the “Swiss Subsidiary Borrower”), IQVIA Solutions Japan K.K., a Japanese stock corporation (kabushiki kaisha) and a subsidiary of the Parent Borrower (the “Japanese Subsidiary Borrower” and together with the Parent Borrower, the U.S. Borrower and the Swiss Subsidiary Borrower, each a “Borrower” and collectively, the “Borrowers”), IQVIA Holdings Inc., a Delaware corporation (“Holdings”), the other guarantors party hereto, Bank of America, N.A., as administrative agent and as collateral agent (in such capacity, the “Administrative Agent”), the Term A-1 Dollar Lenders, the Revolving Credit Lenders and the Amendment No. 2 Increasing U.S. Revolving Credit Lenders (as defined below).
